Recursion Pharmaceuticals, Inc.RXRXNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
23.25
↓ 95% below average
Average (5y)
477.16
Historical baseline
Range
High:1712.76
Low:21.53
CAGR
-57.7%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 23.25 | -40.3% |
| 2023 | 38.94 | +80.8% |
| 2022 | 21.53 | -91.9% |
| 2021 | 264.31 | -67.0% |
| 2020 | 802.16 | -53.2% |
| 2019 | 1712.76 | - |